Valproate and epilepsy: for women as well as men
Open Access
- 23 April 2018
- journal article
- Published by BMJ in Practical Neurology
- Vol. 18 (3) , 222-223
Abstract
Sodium valproate remains the best drug for idiopathic generalised epilepsy. For men with the latter diagnosis, this is the drug of choice. Sodium valproate has an unacceptably high level of major fetal malformation and also causes learning disabilities in many children exposed to the drug in utero. Women of reproductive age should not normally be offered this drug. There are many women with refractory epilepsy who would benefit from this drug and who are not planning pregnancy. Individualised epilepsy care is the gold standard, not blanket bans on drug choice based on gender.Keywords
This publication has 3 references indexed in Scilit:
- Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy RegistersJournal of Neurology, Neurosurgery & Psychiatry, 2014
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Gender Differences in EpilepsyEpilepsia, 2005